Skip to main content
Indietro

Disorders Associated with the Immune System: Hypersensitivity, Autoimmunity, Transplantation, Immunodeficiencies, and AIDS

Guida di studio - Note intelligenti

Appunti personalizzati basati sui tuoi materiali, ampliati con definizioni chiave, esempi e contesto.

Disorders Associated with the Immune System

Hypersensitivity

Hypersensitivity refers to an exaggerated or inappropriate immune response to an antigen, resulting in tissue damage. It occurs when an individual is sensitized by prior exposure to an antigen (allergen). There are four main types of hypersensitivity reactions, each with distinct mechanisms and clinical manifestations.

  • Type I (Anaphylactic): Immediate reaction mediated by IgE antibodies, leading to mast cell and basophil degranulation and release of mediators such as histamine.

  • Type II (Cytotoxic): Antibody-mediated destruction of cells, often involving complement activation.

  • Type III (Immune Complex): Formation of antigen-antibody complexes that deposit in tissues, causing inflammation.

  • Type IV (Delayed Cell-Mediated): T cell-mediated response, typically delayed, resulting in tissue damage.

Hygiene hypothesis: Suggests that reduced exposure to pathogens may decrease immune tolerance and increase hypersensitivity to harmless antigens.

Type of Reaction

Time Before Clinical Signs

Characteristics

Examples

Type I (Anaphylactic)

<30 min

IgE binds to mast cells or basophils, causing degranulation and release of histamine and other mediators

Anaphylaxis, allergic reactions (hay fever, asthma)

Type II (Cytotoxic)

5–12 hours

Antigen causes formation of IgG and IgM antibodies, which bind to target cell and activate complement, resulting in cell lysis

Transfusion reactions, Rh incompatibility

Type III (Immune Complex)

3–8 hours

Antibodies and antigens form complexes that cause inflammation

Arthus reaction, serum sickness

Type IV (Delayed Cell-Mediated)

24–48 hours

Antigens activate T cells, which target cells

Allergic contact dermatitis, transplant rejection

Table 19.1 Types of Hypersensitivity

Type I (Anaphylactic) Reactions

Type I reactions occur within minutes after re-exposure to an allergen. IgE antibodies bind to mast cells and basophils, triggering degranulation and release of mediators such as histamine, leukotrienes, and prostaglandins. These mediators cause increased vascular permeability, smooth muscle contraction, and mucus secretion.

  • Systemic anaphylaxis: Severe, potentially fatal reaction; treated with epinephrine.

  • Localized anaphylaxis: Symptoms depend on the route of entry (e.g., hives, hay fever, asthma).

Mechanism of anaphylaxis Localized anaphylaxis

Preventing Anaphylactic Reactions

Allergy skin tests involve inoculating antigens beneath the epidermis to detect rapid inflammatory reactions (wheal formation). Desensitization therapy involves repeated injections of increasing doses of antigen to stimulate IgG production, which acts as a blocking antibody to neutralize the allergen before it can trigger IgE-mediated responses.

  • Blocking antibody: IgG that intercepts and neutralizes antigens.

Skin test to identify allergens Skin prick test Skin prick test with labeled allergens Positive reaction to skin test

Type II (Cytotoxic) Reactions

Type II reactions involve IgG or IgM antibodies binding to antigens on cell surfaces, activating complement and causing cell lysis or damage by macrophages. This mechanism is important in blood group incompatibilities and certain drug-induced reactions.

  • ABO blood group system: Antibodies form against carbohydrate antigens (A, B, or both) on RBCs. Type O RBCs lack these antigens.

  • Rh blood group system: Rh factor (Rh+) is present in most people. Rh incompatibility can cause hemolytic disease of the newborn (HDNB).

  • Drug-induced cytotoxic reactions: Drugs can bind to platelets or other cells, forming antigenic complexes that are targeted by antibodies.

Blood Group

Erythrocyte or Red Blood Cell Antigens

Plasma Antibodies

Cells That Can Be Received

Frequency in U.S. Population

A

A

Anti-B

A, O

White: 41%, Black: 27%, Asian: 28%

B

B

Anti-A

B, O

White: 10%, Black: 20%, Asian: 27%

AB

A and B

Neither anti-A nor anti-B

A, B, AB, O

White: 4%, Black: 4%, Asian: 7%

O

Neither A nor B

Anti-A and anti-B

O

White: 45%, Black: 49%, Asian: 38%

Table 19.2 The ABO Blood Group System Hemolytic disease of the newborn

Type III (Immune Complex) Reactions

Type III reactions occur when antibodies form against soluble antigens, creating immune complexes that deposit in tissues and activate complement, causing inflammation. This is seen in conditions such as glomerulonephritis and serum sickness.

  • Glomerulonephritis: Immune complexes cause inflammatory damage to kidney glomeruli.

Immune complex-mediated hypersensitivity

Type IV (Delayed Cell-Mediated) Reactions

Type IV reactions are mediated by T cells and occur hours to days after exposure to an antigen. Antigens are phagocytized and presented to T cells, causing sensitization. Upon re-exposure, memory T cells release cytokines that cause tissue damage.

  • Allergic contact dermatitis: Haptens combine with skin proteins, triggering an immune response (e.g., poison ivy, cosmetics, metals, latex).

Mechanism of allergic contact dermatitis (poison ivy) Contact dermatitis skin reaction

Autoimmune Diseases

Mechanisms and Types

Autoimmune diseases occur when the immune system loses self-tolerance and attacks self-antigens, causing organ damage. Self-tolerance is the ability to distinguish self from nonself. Autoimmune diseases are classified as cytotoxic, immune complex, or cell-mediated.

  • Cytotoxic: Antibodies react with cell-surface antigens (e.g., multiple sclerosis, Graves' disease, myasthenia gravis).

  • Immune complex: Immune complexes deposit in tissues (e.g., systemic lupus erythematosus, rheumatoid arthritis).

  • Cell-mediated: T cells attack tissues (e.g., insulin-dependent diabetes mellitus, psoriasis).

Multiple sclerosis: healthy vs. affected nerve Psoriasis skin reaction

Reactions Related to the Human Leukocyte Antigen (HLA) Complex

HLA Complex and Disease Susceptibility

Histocompatibility antigens are self-antigens on cell surfaces encoded by the major histocompatibility complex (MHC). In humans, these genes are called the human leukocyte antigen (HLA) complex. Certain HLAs are associated with increased susceptibility to specific diseases.

Disease

Increased Risk of Occurrence with Specific HLA

Description

Inflammatory diseases

1.5 times

Progressive inflammatory disease affecting nervous system

Endocrine diseases

6–10 times, 40–150 times

Deficiency in production of hormones by adrenal gland; excessive thyroid hormone production

Malignant disease

1.5–2 times

Cancer of lymph nodes

Table 19.3 Diseases Related to Specific HLAs

Transplantation and Graft Types

Transplants may be rejected by T cells, macrophages, and complement-fixing antibodies. Tissue typing is essential to match donor and recipient HLAs. Transplants to privileged sites (e.g., cornea, heart valves) are less likely to be rejected. Stem cells, both embryonic and adult, are used to regenerate tissues and organs.

  • Autograft: Use of one's own tissue.

  • Isograft: Use of identical twin's tissue.

  • Allograft: Use of tissue from another person.

  • Xenotransplantation: Use of nonhuman tissue (e.g., pig heart valves).

Derivation of embryonic stem cells Mouse with human tissue graft Porcine heart valve tissue Common sites for skin graft harvesting

The Immune System and Cancer

Immune Response to Cancer

The immune system removes cancer cells through immune surveillance. Cancer cells express tumor-associated antigens, which are recognized by cytotoxic T lymphocytes (CTLs) and macrophages. However, cancer cells may evade immune detection by rapid reproduction, lack of antigenic epitopes, or becoming vascularized.

CTL interaction with cancer cell

Immunotherapy for Cancer

  • Endotoxins: Stimulate TNF to interfere with cancer blood supply.

  • Vaccines: Used for prophylaxis (e.g., Gardasil for cervical cancer).

  • Monoclonal antibodies: Target specific tumor antigens (e.g., Herceptin).

  • Immunotoxins: Combine monoclonal antibodies with toxic agents to selectively kill tumor cells.

Immunodeficiencies

Types and Examples

Immunodeficiencies are characterized by insufficient immune responses. They may be congenital (due to genetic defects) or acquired (develop during life due to drugs, cancers, or infections).

Disease

Cells Affected

Comments

Acquired immunodeficiency syndrome (AIDS)

Viral destruction of CD4+ T cells

Allows cancer and bacterial, viral, fungal, and protozoan diseases; usually fatal infection

Selective IgA immunodeficiency

B cells

Affects about 1 in 700; causes frequent mucosal infections; specific cause unknown

Common variable immunodeficiency

B cells

Rare; affects adults; increased susceptibility to infections

Severe combined immunodeficiency

T cells and B cells

Rare; affects about 1 in 100,000; severe infections; treated with bone marrow transplant

Table 19.4 Immunodeficiencies

Acquired Immunodeficiency Syndrome (AIDS)

Origin and Structure of HIV

AIDS is caused by the human immunodeficiency virus (HIV), a retrovirus that selectively infects CD4+ T helper cells. HIV originated from cross-species transmission and was first identified in the early 1980s. The virus contains two identical RNA strands, a phospholipid envelope, and glycoprotein spikes (gp120 and gp41).

Structure of HIV and infection of CD4+ T cell

HIV Infectiveness and Pathogenicity

HIV spreads via dendritic cells and macrophages to lymphoid organs, where it infects activated T helper cells. The gp120 spike binds to the CD4 receptor and CCR5 or CXCR4 coreceptors, facilitating viral entry. Once inside, viral RNA is reverse transcribed into DNA and integrated into the host genome.

HIV attachment and entry into CD4+ T cell

Latent and Active HIV Infection

HIV infection can be latent (provirus integrated into host DNA) or active (new viruses bud from the host cell). Latently infected cells serve as reservoirs for HIV, making eradication difficult. The virus undergoes rapid antigenic changes and mutation.

Latent and active HIV infection in CD4+ T cells Latent and active HIV infection in macrophages and dendritic cells

Subtypes and Stages of HIV Infection

  • HIV-1: Most common, related to chimpanzee viruses.

  • HIV-2: Less pathogenic, related to monkey viruses.

The progression of HIV infection occurs in three phases:

  1. Phase 1: Asymptomatic or lymphadenopathy

  2. Phase 2: Steady decline in CD4+ T cells; persistent infections

  3. Phase 3: AIDS develops; CD4+ count below 200 cells/μl; indicator conditions

Progression of HIV infection

HIV Transmission and Global Impact

HIV is transmitted via intimate sexual contact, breast milk, transplacental infection, contaminated needles, organ transplants, and blood transfusion. The virus survives for hours outside cells and days inside cells. The global impact is significant, with the highest prevalence in sub-Saharan Africa.

Distribution of HIV infection and AIDS worldwide

Preventing and Treating AIDS

Prevention includes condom use, discouraging sexual promiscuity, and sterile needles. Treatment involves antiretroviral drugs targeting various stages of the HIV life cycle:

  • Fusion/entry inhibitors: Block viral entry (e.g., enfuvirtide, maraviroc).

  • Reverse transcriptase inhibitors: Block viral RNA to DNA conversion (e.g., tenofovir, emtricitabine, efavirenz).

  • Integrase inhibitors: Prevent integration of viral DNA (e.g., raltegravir).

  • Protease inhibitors: Prevent maturation of viral proteins (e.g., atazanavir, indinavir, saquinavir).

  • Maturation inhibitors: Tetherins prevent viral release.

Highly active antiretroviral therapy (HAART) uses drug combinations to minimize resistance.

Drugs that inhibit HIV life cycle

Pearson Logo

Study Prep